Texas Health Catalyst supports the translation of promising ideas and discoveries into solutions that improve health outcomes and lower health care costs. The program provides support through timely and customized guidance on the research and development pathway from industry and clinical experts (Phase 1 awards), as well as seed funding for awardees (Phase 2 awards of $5K-$50K per project).

Dell Medical School’s Health Transformation Research Institute provides leadership and infrastructure to support robust, innovative, and world-class clinical and late-stage (T3-T5) translational research. The Health Transformation Research Institute supports researchers and learners conducting translational investigation, as well as the development of an integrated learning health system in which research is embedded in, drives and reinforces excellence in clinical, educational, and community-focused missions.